These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7872808)

  • 1. Characterization of the glycosaminoglycan-binding region of lactoferrin.
    Wu HF; Monroe DM; Church FC
    Arch Biochem Biophys; 1995 Feb; 317(1):85-92. PubMed ID: 7872808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
    Alberdi E; Hyde CC; Becerra SP
    Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of heparin activity by neutrophil lactoferrin.
    Wu HF; Lundblad RL; Church FC
    Blood; 1995 Jan; 85(2):421-8. PubMed ID: 7811995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycan specificity of a heparin-binding peptide.
    Taylor GJ; Yorke SC; Harding DR
    Pept Res; 1995; 8(5):286-93. PubMed ID: 8589551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT; Sié P
    Thromb Haemost; 1988 Dec; 60(3):399-406. PubMed ID: 2976993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP; Tollefsen DM; Sadler JE
    J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serpin-glycosaminoglycan interactions.
    Rein CM; Desai UR; Church FC
    Methods Enzymol; 2011; 501():105-37. PubMed ID: 22078533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of frog and chicken cDNAs encoding heparin cofactor II.
    Colwell NS; Tollefsen DM
    Thromb Haemost; 1998 Nov; 80(5):784-90. PubMed ID: 9843172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the high affinity heparin binding site of the Alzheimer's disease beta A4 amyloid precursor protein (APP) and its enhancement by zinc(II).
    Multhaup G; Mechler H; Masters CL
    J Mol Recognit; 1995; 8(4):247-57. PubMed ID: 8588942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
    Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
    Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lysine 173 in heparin binding to heparin cofactor II.
    Whinna HC; Blinder MA; Szewczyk M; Tollefsen DM; Church FC
    J Biol Chem; 1991 May; 266(13):8129-35. PubMed ID: 1902471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General features of the heparin-binding serpins antithrombin, heparin cofactor II and protein C inhibitor.
    Pratt CW; Church FC
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):479-90. PubMed ID: 8392392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing determines the binding of platelet-derived growth factor (PDGF-AA) to glycosaminoglycans.
    Lustig F; Hoebeke J; Ostergren-Lundèn G; Velge-Roussel F; Bondjers G; Olsson U; Rüetschi U; Fager G
    Biochemistry; 1996 Sep; 35(37):12077-85. PubMed ID: 8810913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
    Van Deerlin VM; Tollefsen DM
    J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.